Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Clinical trial NCT06033833 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT06033833

Sponsor

Sanofi

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2023-09-05

Primary completion

2026-09-29

Enrollment

335

View on ClinicalTrials.gov